Search term: media
PHARMAC documents that matched your search:
PHARMAC exceeds its targets with hospital contracts
(2 pages, 35 KB)
Negotiations for national hospital pharmaceutical expenditure are producing better than expected results, Government drug-buying agency PHARMAC says. Supply contracts have been agreed with nine different pharmaceutical suppliers, covering 69 different chemicals.
The number of people able to have subsidised access to a treatment for anaemia associated with kidney failure is set to nearly double following an agreement between PHARMAC and Roche Products.
Almost 40,000 New Zealanders have access to better health as a result of pharmaceutical funding decisions made in the 2002 financial year. PHARMAC’s 2002 Annual Review, published today, highlights that new or or expanded access was provided to 24 different pharmaceuticals and produced savings worth more than $36 million in the 2002 financial year.
New Zealand will become one of the first countries in the world to fund imatinib mesylate (Glivec) as a first line treatment for chronic myeloid leukaemia, should the new therapy be approved for this use by the Ministry of Health. PHARMAC has agreed to fund Glivec for all patients for whom it is currently approved for use.
PHARMAC has reached a provisional agreement with Novartis to fund the cancer drug Glivec for a wide group of New Zealanders. PHARMAC is asking for submissions on its funding proposal, which involves a number of products and is subject to the outcome of consultation and final approval by the PHARMAC Board.
Hon Annette King National hospital drug buying strategy agreed Health Minister Annette King says a national pharmaceutical purchasing strategy will provide consistency and equitable access…
Health Minister Annette King says a national pharmaceutical purchasing strategy will provide consistency and equitable access to hospital drugs throughout New Zealand. Ms King has approved the National Hospital Pharmaceutical Purchasing Strategy, which will see Pharmac, the Government’s drug-buying agency, authorised to work collaboratively with individual DHBs to purchase hospital drugs.